These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1010 related articles for article (PubMed ID: 32267987)

  • 41. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures.
    Hui KPY; Cheung MC; Perera RAPM; Ng KC; Bui CHT; Ho JCW; Ng MMT; Kuok DIT; Shih KC; Tsao SW; Poon LLM; Peiris M; Nicholls JM; Chan MCW
    Lancet Respir Med; 2020 Jul; 8(7):687-695. PubMed ID: 32386571
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model.
    Rockx B; Kuiken T; Herfst S; Bestebroer T; Lamers MM; Oude Munnink BB; de Meulder D; van Amerongen G; van den Brand J; Okba NMA; Schipper D; van Run P; Leijten L; Sikkema R; Verschoor E; Verstrepen B; Bogers W; Langermans J; Drosten C; Fentener van Vlissingen M; Fouchier R; de Swart R; Koopmans M; Haagmans BL
    Science; 2020 May; 368(6494):1012-1015. PubMed ID: 32303590
    [TBL] [Abstract][Full Text] [Related]  

  • 43. COVID-19: a conundrum to decipher.
    Deshmukh V; Tripathi SC; Pandey A; Deshmukh V; Vykoukal J; Patil A; Sontakke B
    Eur Rev Med Pharmacol Sci; 2020 May; 24(10):5830-5841. PubMed ID: 32495923
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The outbreak of the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): A review of the current global status.
    Bchetnia M; Girard C; Duchaine C; Laprise C
    J Infect Public Health; 2020 Nov; 13(11):1601-1610. PubMed ID: 32778421
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.
    Hon KL; Leung KKY; Leung AKC; Sridhar S; Qian S; Lee SL; Colin AA
    Pediatr Pulmonol; 2020 Jul; 55(7):1584-1591. PubMed ID: 32483934
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Coronavirus disease 2019 (COVID-19): A literature review.
    Harapan H; Itoh N; Yufika A; Winardi W; Keam S; Te H; Megawati D; Hayati Z; Wagner AL; Mudatsir M
    J Infect Public Health; 2020 May; 13(5):667-673. PubMed ID: 32340833
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies.
    Sharma A; Tiwari S; Deb MK; Marty JL
    Int J Antimicrob Agents; 2020 Aug; 56(2):106054. PubMed ID: 32534188
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SARS-CoV-2 infection in immunocompromised patients: humoral versus cell-mediated immunity.
    Wei J; Zhao J; Han M; Meng F; Zhou J
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32727811
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical, molecular, and epidemiological characterization of the SARS-CoV-2 virus and the Coronavirus Disease 2019 (COVID-19), a comprehensive literature review.
    Ortiz-Prado E; Simbaña-Rivera K; Gómez-Barreno L; Rubio-Neira M; Guaman LP; Kyriakidis NC; Muslin C; Jaramillo AMG; Barba-Ostria C; Cevallos-Robalino D; Sanches-SanMiguel H; Unigarro L; Zalakeviciute R; Gadian N; López-Cortés A
    Diagn Microbiol Infect Dis; 2020 Sep; 98(1):115094. PubMed ID: 32623267
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on viral pneumonia related to novel coronavirus SARS-CoV-2, SARS-CoV, and MERS-CoV: a literature review.
    Liya G; Yuguang W; Jian L; Huaiping Y; Xue H; Jianwei H; Jiaju M; Youran L; Chen M; Yiqing J
    APMIS; 2020 Jun; 128(6):423-432. PubMed ID: 32363707
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Immunologic aspects of characteristics, diagnosis, and treatment of coronavirus disease 2019 (COVID-19).
    Chang FY; Chen HC; Chen PJ; Ho MS; Hsieh SL; Lin JC; Liu FT; Sytwu HK
    J Biomed Sci; 2020 Jun; 27(1):72. PubMed ID: 32498686
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
    Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
    Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Coronaviruses: An Updated Overview of Their Replication and Pathogenesis.
    Wang Y; Grunewald M; Perlman S
    Methods Mol Biol; 2020; 2203():1-29. PubMed ID: 32833200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The novel zoonotic COVID-19 pandemic: An expected global health concern.
    Contini C; Di Nuzzo M; Barp N; Bonazza A; De Giorgio R; Tognon M; Rubino S
    J Infect Dev Ctries; 2020 Mar; 14(3):254-264. PubMed ID: 32235085
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Cell-Mediated Immune Responses to COVID-19 Infection.
    Guihot A; Litvinova E; Autran B; Debré P; Vieillard V
    Front Immunol; 2020; 11():1662. PubMed ID: 32719687
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Expansion of SARS-CoV-2-Specific Antibody-Secreting Cells and Generation of Neutralizing Antibodies in Hospitalized COVID-19 Patients.
    Varnaitė R; García M; Glans H; Maleki KT; Sandberg JT; Tynell J; Christ W; Lagerqvist N; Asgeirsson H; Ljunggren HG; Ahlén G; Frelin L; Sällberg M; Blom K; Klingström J; Gredmark-Russ S
    J Immunol; 2020 Nov; 205(9):2437-2446. PubMed ID: 32878912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Adaptive immune responses to SARS-CoV-2 infection in severe versus mild individuals.
    Zhang F; Gan R; Zhen Z; Hu X; Li X; Zhou F; Liu Y; Chen C; Xie S; Zhang B; Wu X; Huang Z
    Signal Transduct Target Ther; 2020 Aug; 5(1):156. PubMed ID: 32796814
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [What we learned from SARS may provide important insights into understanding and management of coronavirus disease 2019].
    Liu YJ; Yang YL; Xu Y
    Zhonghua Jie He He Hu Xi Za Zhi; 2020 Apr; 43(4):339-344. PubMed ID: 32294817
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lessons for COVID-19 Immunity from Other Coronavirus Infections.
    Sariol A; Perlman S
    Immunity; 2020 Aug; 53(2):248-263. PubMed ID: 32717182
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Of Mice and Men: The Coronavirus MHV and Mouse Models as a Translational Approach to Understand SARS-CoV-2.
    Körner RW; Majjouti M; Alcazar MAA; Mahabir E
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32806708
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 51.